HM2018-32 A Phase 1b Open-Label Study to Evaluate the Safety and Antitumor Activity of LoncastuximabTesirine and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

Pongas, Georgios (PI)

Clinical and Translational Science Institute
Medicine - Hematology, Oncology, Transplant

Project: Research project

Project Details

Description

HM2018-32 A Phase 1b Open-Label Study to Evaluate the Safety and Antitumor Activity of Loncastuximab Tesirine and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

Status	Active
Effective start/end date	11/1/18 → 10/30/22

Funding

ADC THERAPEUTICS SA

View all

View less

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.